A simple, rapid and highly efficient method was developed for introducing specific DNA sequences into a defined locus of the herpes simplex virus type 1 (HSV-1) genome by restriction enzyme cleavage and ligation. The HSV-1 strain HFEM does not contain any PacI site, thus two unique PacI sites flanking an HSV-1 ICP6 promoter-LacZ cassette were engineered into the latency-associated transcript (LAT) region to generate a recombinant virus HFEM/ICP6-LacZ which produced blue plaques in the presence of X-gal. HFEM/ICP6-LacZ was then used to test the in vitro ligation and transfection system by digesting HFEM/ICP6-LacZ with PacI and SwaI (an endogenous unique site upstream of the LAT promoter locus) and inserting a PacI-SwaI fragment containing LA...
We describe the construction of a novel herpes simplex virus (HSV) vector containing a unique XbaI r...
Overview summary Development of suitable vectors for transfer of genes to the central nervous system...
To obtain knowledge about the helper-virus-free packaging system of HSV-1 vector and its use in cult...
The natural history of Herpes simplex virus type 1 (HSV-1) infection in humans suggests its potentia...
Although attenuated retroviral vectors provide an acceptable gene transfer vector system for many ce...
The ability of herpes simplex virus type 1 (HSV-1) to establish a lifelong, transcriptionally active...
The ability to direct foreign gene expression from the herpes simplex virus type 1 (HSV-1) genome du...
Herpes Simplex Virus (HSV) is potentially an ideal vector for gene therapy in the peripheral nervous...
Manipulation of gene expression in developing or in mature central nervous systems (CNS) holds a pro...
Herpes simplex virus type 1 (HSV-1) vectors have now been developed and enable the efficient deliver...
The herpes simplex virus type 1 (HSV-1) latency associated promoter (LAP) has been shown to sustain ...
Genetic diseases arise from the aberrant expression of genes. These disorders can potentially be tre...
During herpes simplex virus type 1 (HSV-1) latency, limited viral transcription takes place. This tr...
AbstractTo develop means to explore viral gene expression in ganglia without laborious histological ...
A major feature of the biology of herpes simplex virus type 1 (HSV-1) is it's capacity to establish ...
We describe the construction of a novel herpes simplex virus (HSV) vector containing a unique XbaI r...
Overview summary Development of suitable vectors for transfer of genes to the central nervous system...
To obtain knowledge about the helper-virus-free packaging system of HSV-1 vector and its use in cult...
The natural history of Herpes simplex virus type 1 (HSV-1) infection in humans suggests its potentia...
Although attenuated retroviral vectors provide an acceptable gene transfer vector system for many ce...
The ability of herpes simplex virus type 1 (HSV-1) to establish a lifelong, transcriptionally active...
The ability to direct foreign gene expression from the herpes simplex virus type 1 (HSV-1) genome du...
Herpes Simplex Virus (HSV) is potentially an ideal vector for gene therapy in the peripheral nervous...
Manipulation of gene expression in developing or in mature central nervous systems (CNS) holds a pro...
Herpes simplex virus type 1 (HSV-1) vectors have now been developed and enable the efficient deliver...
The herpes simplex virus type 1 (HSV-1) latency associated promoter (LAP) has been shown to sustain ...
Genetic diseases arise from the aberrant expression of genes. These disorders can potentially be tre...
During herpes simplex virus type 1 (HSV-1) latency, limited viral transcription takes place. This tr...
AbstractTo develop means to explore viral gene expression in ganglia without laborious histological ...
A major feature of the biology of herpes simplex virus type 1 (HSV-1) is it's capacity to establish ...
We describe the construction of a novel herpes simplex virus (HSV) vector containing a unique XbaI r...
Overview summary Development of suitable vectors for transfer of genes to the central nervous system...
To obtain knowledge about the helper-virus-free packaging system of HSV-1 vector and its use in cult...